60 related articles for article (PubMed ID: 3824430)
1. Netilmicin in gram-negative sepsis: comparative abilities of a dosage nomogram and clinical microbiologists to predict the preferred individual dose.
Batra HK; Mawer GE; Ganguli LA; Keaney MG; Noone P
Ther Drug Monit; 1986; 8(4):440-5. PubMed ID: 3824430
[TBL] [Abstract][Full Text] [Related]
2. High dose netilmicin therapy of severe or chronic infections.
Hellum KB; Madsen ST; Digranes A; Stokstad S; Solberg CO
Scand J Infect Dis Suppl; 1980; Suppl 23():189-94. PubMed ID: 6937967
[TBL] [Abstract][Full Text] [Related]
3. Netilmicin 200 mg twice a day for adult patients with life-threatening infections. A preliminary report.
Perera MR; Amirak ID; Noone P
Scand J Infect Dis Suppl; 1980; Suppl 23():186-8. PubMed ID: 6937966
[TBL] [Abstract][Full Text] [Related]
4. Netilmicin kinetics in urology.
Astobieta A; Calvo R; Aguirre C; RodrÃguez-Sasiain JM
Int J Clin Pharmacol Ther Toxicol; 1993 Nov; 31(11):557-60. PubMed ID: 8294169
[TBL] [Abstract][Full Text] [Related]
5. Renal tolerability of four different once-daily dose regimen of netilmicin in critical care patients.
Laczika K; Staudinger T; Hollenstein U; Presterl E; Locker GJ; Knapp S; Burgmann H; Stoiser B; Kofler J; Winter W; Graninger W; Frass M
Wien Klin Wochenschr; 1997 Nov; 109(21):840-4. PubMed ID: 9408981
[TBL] [Abstract][Full Text] [Related]
6. Netilmicin use in pediatric patients.
Chindasilpa V; Schauf V; Hamilton LR; Riff LJ
Dev Pharmacol Ther; 1980; 1(4):238-53. PubMed ID: 7438970
[TBL] [Abstract][Full Text] [Related]
7. Serum cystatin C for the prediction of glomerular filtration rate with regard to the dose adjustment of amikacin, gentamicin, tobramycin, and vancomycin.
Hermida J; Tutor JC
Ther Drug Monit; 2006 Jun; 28(3):326-31. PubMed ID: 16778715
[TBL] [Abstract][Full Text] [Related]
8. Netilmicin in the treatment of severe or complicated urinary tract infections.
Peddie BA; Bailey RR; Blake E; Summerfield MJ
N Z Med J; 1980 May; 91(660):378-81. PubMed ID: 6931321
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of netilmicin-cefoxitin and gentamicin-cefoxitin in surgical patients with serious systemic infection.
Bubrick MP; Howard RJ; Pancorbo S; Lorber RR; Chin TW; Yost R
Clin Ther; 1983; 5(5):515-24. PubMed ID: 6352035
[TBL] [Abstract][Full Text] [Related]
10. Netilmicin therapy of patients with septicaemia and other severe infections.
Brandenhoff P; Stafanger G; Gammelgaard PA; Rasmussen F; Jensen SH; Bretlau P; Thomsen VF
Scand J Infect Dis Suppl; 1980; Suppl 23():181-5. PubMed ID: 6937965
[TBL] [Abstract][Full Text] [Related]
11. [Adjusting the dosage of netilmicin from two measurements. Program validation].
Guedes Y; Abgrall JF; Lebot MA; Voirin T; L'Azou D; Dheilly M; Tanguy RL; Le Garrec J
Therapie; 1989; 44(5):323-6. PubMed ID: 2814913
[TBL] [Abstract][Full Text] [Related]
12. Netilmicin in moderate to severe infections in newborns and infants: a study of efficacy, tolerance and pharmacokinetics.
Henriksson P; Svenningsen NW; Juhlin I; Haeger K
Scand J Infect Dis Suppl; 1980; Suppl 23():155-9. PubMed ID: 7010546
[TBL] [Abstract][Full Text] [Related]
13. Multicenter comparative evaluation of netilmicin and gentamicin in adult patients. Efficacy and safety.
Herting RL; Lorber RR; Miller M; Danzig MR
Arzneimittelforschung; 1981; 31(2):366-70. PubMed ID: 7194655
[TBL] [Abstract][Full Text] [Related]
14. Netilmicin therapy of serious renal and urinary tract infections in patients with normal and impaired renal function.
Denneberg T; Haeger K; Juhlin I
Scand J Infect Dis Suppl; 1980; Suppl 23():135-40. PubMed ID: 6937958
[TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of netilmicin-ticarcillin and tobramycin-ticarcillin in the treatment of serious systemic infections in elderly patients.
Jansen W; Schwarz A
Clin Ther; 1984; 7(1):112-20. PubMed ID: 6394127
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial-induced endotoxaemia in patients with sepsis in the field of acute pyelonephritis.
Giamarellos-Bourboulis EJ; Perdios J; Gargalianos P; Kosmidis J; Giamarellou H
J Postgrad Med; 2003; 49(2):118-22. PubMed ID: 12867685
[TBL] [Abstract][Full Text] [Related]
17. Increased burn patient survival with individualized dosages of gentamicin.
Zaske DE; Bootman JL; Solem LB; Strate RG
Surgery; 1982 Feb; 91(2):142-9. PubMed ID: 7058491
[TBL] [Abstract][Full Text] [Related]
18. Clinical use of a one-compartment model for determining netilmicin pharmacokinetic parameters and dosage recommendations.
Rotschafer JC; Crossley KB; Zaske DE; Russillo NJ; Strate RG; Tofte RW; Solem LD
Ther Drug Monit; 1983; 5(3):263-7. PubMed ID: 6636253
[TBL] [Abstract][Full Text] [Related]
19. Prospective, randomized comparison of the efficacy and safety of netilmicin-clindamycin and tobramycin-clindamycin in the treatment of serious systemic infections.
Kahalley S; Chandler J; Hawkins J; Norris G; Waugespack R; Snow RM
Clin Ther; 1985; 7(4):497-506. PubMed ID: 4016829
[TBL] [Abstract][Full Text] [Related]
20. A prospective randomized trial of ceftazidime versus netilmicin plus mezlocillin in the empirical therapy of presumed sepsis in cirrhotic patients.
McCormick PA; Greenslade L; Kibbler CC; Chin JK; Burroughs AK; McIntyre N
Hepatology; 1997 Apr; 25(4):833-6. PubMed ID: 9096584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
